Antibodies under a microscope

PX-TA1392

Monalizumab Biosimilar – Anti-KLRC1/ NKG2A/ CD159a/ CD94 mAb – Research Grade

Description

Monalizumab Biosimilar - Anti-KLRC1/ NKG2A/ CD159a/ CD94 mAb - Research Grade

Target

KLRC1/ NKG2A/ CD159a/ CD94

Target Alias Name

Monalizumab/IPH-2201/NN-8765/NNC-0141-0000-0100/NNC-141-01000/anti-NKG2A/humZ270/KLRC1/ NKG2A/ CD159a/ CD94/anti-KLRC1/ NKG2A/ CD159a/ CD94

Isotype/Mimetic

IgG4-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression